Aetion Publishes 2021 eBook Showcasing RWE in Successful FDA Submissions
Aetion has published an eBook following an investigation into when and how real world evidence (RWE) successfully supports submissions to [...]
Aetion eBook Highlights the Impact of RWE in Successful Drug Approvals Ahead of FDA Framework
Aetion has published an eBook detailing how real world data (RWD) and real world evidence (RWE) can impact drug approvals [...]
Part 2 of Aetion’s ICPE Research Spotlight Highlights RWD in COVID-19 Research and Updated RWE Guidance
According to Aetion, key highlights of the August ICPE All Access Meeting hosted by the International Society for Pharmacology (ISPE) [...]
Aetion and NICE Partner to Leverage RWE in Comparative Effectiveness Studies
Aetion and the National Institute for Health and Care Excellence (NICE) have announced a partnership intended to advance comparative effectiveness [...]
Syneos Health Executive VP and Data Expert Discusses RWE and Aetion Collaboration
Executive Vice President of Real World Evidence (RWE) and Late Phase at Syneos Health Javier Jimenez discusses major industry trends [...]
Aetion and Quinten Health Announce Partnership to Facilitate RWE Studies and Improve Patient Outcomes
Aetion and artificial intelligence (AI) company Quinten Health have announced a partnership aimed at improving real world evidence (RWE) offerings [...]
IMPACT HTA Issues Recommendations on RWE in Decision-Making, Highlights Transparency
IMPACT Health Technology Assessment (HTA) has issued a series of recommendations intended to inform decision-makers using real world evidence (RWE). [...]
Aetion Researchers Discuss ICER’s Reassessment of Drugs Receiving Accelerated FDA Approval Using RWE
The Institute for Clinical and Economic Review (ICER) recently published findings from a pilot study that used real world evidence [...]
ICER Revises 2018 Hereditary Angioedema Report Using RWE, Recommends Up to 75% Price Reduction
Researchers at the Institute for Clinical and Economic Review (ICER), Aetion, and the University of Washington collaborated to determine how [...]
Syneos Health and Aetion Announce Partnership in Push for RWD in Regulatory Applications
Syneos Health and Aetion will partner to further their drug development efforts using real world data (RWD). The collaboration is [...]
Aetion eBook Notes Half of 2019 Submissions to FDA Included RWE
Aetion has released an eBook detailing trends in regulatory submissions that include real world evidence (RWE). Aetion notes that approximately [...]
Aetion and Cegedim Health to Continue Rewarding RWD Partnership to Track Medication Efficacy and Safety
Aetion and Cegedim Health have announced that they will continue their real world data (RWD) partnership. The collaboration combines Aetion’s [...]
Aetion Researchers Highlight RWE Best Practices
Aetion researchers discuss their recent article, published in the Journal of Comparative Effectiveness Research. The work is a result of [...]
How Can RWE Advance Chronic Disease Research and Inform Decision-Makers?
Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham [...]
Discussion on the Power of RWE in Drug Development and Market Access
Aetion invited two leaders in real world evidence (RWE) to share their thoughts on industry trends. Chief Data Science Officer [...]
NICE Policy Leader Discusses RWE Trends and Global Impact of COVID-19
The UK’s National Institute for Health and Care Excellence (NICE) recently put forth a five-year strategy plan where it includes guidelines [...]
Aetion Discussion on RWE Solutions for Providers and Payers
Aetion’s Senior Vice President of Payer Solutions William Guptail discusses how real world evidence (RWE) can inform both payer and [...]
RWE Alliance Launches to Accelerate RWE Use Guidelines and to Inform Policy
Aetion has announced a real world evidence (RWE) coalition. The RWE Alliance is also composed of IQVIA, Tempus, Syapse, and [...]
Aetion Announces $212 Million in Total Funding as RWE Momentum Builds
Aetion raised an additional $110 million in Series C funding, making its total funding $212 million. The real world evidence [...]
Does Hydroxychloroquine Work? New COVID-19 Evidence Accelerator Report Uses RWD to Determine Patient Outcomes
The COVID-19 Evidence Accelerator has published a new report in PLOS One. The manuscript examines how hydroxychloroquine and azithromycin affect [...]
How Will Europe Use RWE in Regulatory Decisions and HTAs?
Aetion’s Senior Director of European Business Development Pierre Engel discusses trends in Europe’s use of real world evidence (RWE). He [...]
Aetion President and Co-Founder Discusses RWE in Recent Coronavirus Study
Aetion Co-Founder and President Jeremy Rassen discusses the use of real world evidence (RWE) in a recent Science paper. Researchers [...]
NICE’s Five-Year Plan Features RWE and RWD
Aetion’s Scientific Partnerships Lead Ashley Jaksa discusses the four new strategies released by the UK’s National Institute for Health and [...]
Aetion Analyst Discusses Using RWE in Rare Disease Clinical Trials
Senior Scientific Analyst Adina Estrin at Aetion discusses how RWE (real world evidence) can be used in constructing external control [...]
ICER and Aetion Collaborate to Use RWE in Hereditary Angioedema Pilot Study
ICER recently announced a partnership with Aetion. ICER will use Aetion’s RWE (real world evidence) in revising its assessment on [...]